Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huiguo Liu

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Oncology Reports|October 18, 2016
Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathwaysGuangcai Li, Yuan He, Jun Yao, et al.
Expert Opinion on Drug Safety|October 18, 2024
Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance systemZhenyu Mao, Yuchen Huang, Xiaoyan Zhu, et al.
Heliyon|September 26, 2024
Effect of the lack of access to handwashing facilities on the global burden of lower respiratory infections, 1990-2019: A systematic analysis from the global burden of disease study 2019Zhenyu Mao, Xiaoyan Zhu, Yuchen Huang, et al.
Experimental Hematology & Oncology|March 1, 2024
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practiceLing Zhou, Yunlong Lu, Wei Liu, et al.
Respiratory Research|October 29, 2025
Single-cell landscape of mouse lungs exposed to intermittent hypoxiaPengdou Zheng, Lingling Wang, Xiaoyan Zhu, et al.
Expert Opinion on Drug Safety|February 12, 2025
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system databaseLingling Wang, Zhenyu Mao, Pengdou Zheng, et al.
Chinese Medical Journal|December 8, 2024
Unveiling the molecular and cellular links between obstructive sleep apnea-hypopnea syndrome and vascular agingWei Liu, Le Zhang, Wenhui Liao, et al.
Respiratory Medicine|April 14, 2025
The role and research progress of epigenetic modifications in obstructive sleep apnoea-hypopnea syndrome and related complicationsXiaoyan Zhu, Zhenyu Mao, Pengdou Zheng, et al.
Peerj|June 21, 2024
Recognition of apnea and hypopnea by non-contact optical fiber mattress and its application in the diagnosis of obstructive sleep apnea hypopnea syndrome: a retrospective studyLing Zhou, Xiaoyan Zhu, Lu Liu, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 10, 2015
YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channelsZaiwen Fan, Bo Liu, Shuai Zhang, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Oncology Reports|October 18, 2016
Angelicin inhibits human lung carcinoma A549 cell growth and migration through regulating JNK and ERK pathwaysGuangcai Li, Yuan He, Jun Yao, et al.
Expert Opinion on Drug Safety|October 18, 2024
Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance systemZhenyu Mao, Yuchen Huang, Xiaoyan Zhu, et al.
Heliyon|September 26, 2024
Effect of the lack of access to handwashing facilities on the global burden of lower respiratory infections, 1990-2019: A systematic analysis from the global burden of disease study 2019Zhenyu Mao, Xiaoyan Zhu, Yuchen Huang, et al.
Experimental Hematology & Oncology|March 1, 2024
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practiceLing Zhou, Yunlong Lu, Wei Liu, et al.
Respiratory Research|October 29, 2025
Single-cell landscape of mouse lungs exposed to intermittent hypoxiaPengdou Zheng, Lingling Wang, Xiaoyan Zhu, et al.
Expert Opinion on Drug Safety|February 12, 2025
Assessment of Riociguat-related adverse events: a disproportionality analysis utilizing the FDA adverse event reporting system databaseLingling Wang, Zhenyu Mao, Pengdou Zheng, et al.
Chinese Medical Journal|December 8, 2024
Unveiling the molecular and cellular links between obstructive sleep apnea-hypopnea syndrome and vascular agingWei Liu, Le Zhang, Wenhui Liao, et al.
Respiratory Medicine|April 14, 2025
The role and research progress of epigenetic modifications in obstructive sleep apnoea-hypopnea syndrome and related complicationsXiaoyan Zhu, Zhenyu Mao, Pengdou Zheng, et al.
Peerj|June 21, 2024
Recognition of apnea and hypopnea by non-contact optical fiber mattress and its application in the diagnosis of obstructive sleep apnea hypopnea syndrome: a retrospective studyLing Zhou, Xiaoyan Zhu, Lu Liu, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 10, 2015
YM155, a selective survivin inhibitor, reverses chronic hypoxic pulmonary hypertension in rats via upregulating voltage-gated potassium channelsZaiwen Fan, Bo Liu, Shuai Zhang, et al.
Pageof 9